Midgard Science

OmniParticles

Seoul, South Korea omniparticles.com

From their website, Nov 2026

Work here? Claim this listing

About

OmniParticles is a nanomedicine CDMO that develops nanoparticle drug substances and provides aseptic fill-finish for clinical-phase drug products. It operates in Seoul, Korea, with separate drug substance and drug product GMP facilities in the same building.

Services

  • Nanoparticle drug substance CDMO

    End-to-end development and manufacturing for nanoparticle drug substances, from concept translation and formulation refinement through scale-up and GMP mass production with CMC support.

  • Aseptic sterile fill-finish

    Aseptic fill-finish for preclinical and Phase I/II/III clinical supply, including batches of 2,000–5,000 vials under Grade A conditions in open RABS with a fully single-use product-contact train.

  • GMP and non-GMP drug substance manufacturing

    Manufacturing of nanomedicine drug substance from preparation to purified bulk with GMP-compliant processes.

  • QC/QA analysis

    QC/QA protocols for verifying nanomedicine integrity, safety, and performance against global regulatory standards.

  • Batch records and release documentation

    Preparation of manufacturing reports, CoT, and CoA with full traceability to support regulatory filings.

  • CMC documentation and Module 3 CTD support

    Preparation of essential CMC documentation and Module 3 scientific and technical writing for global regulatory submissions.

  • Regulatory consulting

    Guidance on early-development regulatory strategy and global frameworks for IND and related clinical trial applications.

Capabilities

Assays and studies
Fill-finish · Small molecules · Peptides · LNP · DLS · TEM · Zeta-potential · HPLC · SEC · ICP-MS · Sterility testing
Scale and capacity
Batches of 2,000–5,000 vials · GMP drug substance manufacturing plant · Purpose-built sterile drug product suite · Two manufacturing suites
Therapeutic areas
Acute diseases · Chronic diseases · Inflammatory diseases · Ischemic stroke · Intracerebral hemorrhage · Sepsis · Subarachnoid hemorrhage · Traumatic brain injury

Instruments and platforms

  • DLS
  • TEM
  • Zeta-potential
  • HPLC
  • SEC mode
  • Triple detector
  • ICP-MS

Modalities and species

Modalities
Small molecule · Antibody · Peptide · LNP / formulation

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: drug substance manufacturing and facility operations

Company

Type
CRDMO
Founded
2011

Locations

Address
Engineering 2021, 7 (9), 4446–4453 •Biomaterials 2020, 239, 119859 •ACS Nano
Sites
Seoul, Korea
Serves
global

Similar labs

Work here? Claim this listing